Legato Capital Management LLC
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 1442641
San Francisco, CA
Position in IRWD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$547,767
New position
Shares Held
156,059
first reported quarter
Ownership
0.095%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Legato Capital Management LLC holds $15,801,793 across 13 Drug Manufacturers - Specialty & Generic names. IRWD ranks #12 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
70,805 | $3,409,260 | |
| 2 | SIGA |
Siga Technologies Inc
|
512,039 | $2,739,408 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
40,644 | $2,408,969 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
234,144 | $1,358,035 | |
| 5 | LQDA |
Liquidia Corp
|
24,516 | $925,233 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
39,007 | $881,558 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
87,010 | $828,335 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
14,108 | $729,242 |
All Filings in IRWD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $547,767 | 156,059 | Shares | Other | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||